Table 1.
Salivary gland neoplasms | 49.5% |
Benign salivary gland neoplasms | 36.4% |
Pleomorphic adenoma | 31 (31.3%) |
Monomorphic | 4 (4.0%) |
Warthin | 1 (1.0%) |
Malignant salivary gland neoplasms | 13.1% |
Adenoid cystic carcinoma | 4 (4.0%) |
Carcinoma ex pleomorphic adenoma | 3 (3.0%) |
Adenocarcinoma NOS | 3 (3.0%) |
Acinic cell carcinoma | 2 (2.0%) |
Myoepithilial carcinoma | 1 (1.0%) |
Neurogenic neoplasms | 41.4% |
Paraganglioma | 30 (30.3%) |
Carotid body paraganglioma | 20 |
Vagal paraganglioma | 17 |
Jugular paraganglioma | 1 |
Schwannoma | 9 (9.1%) |
Neurofibroma | 2 (2.0%) |
Miscellaneous lesions | 9.1% |
(Lympho)vascular malformation | 2 (2.0%) |
Lymphoma non-Hodgkin | 1 (1.0%) |
Rhabdomyoma | 1 (1.0%) |
Rhabdomyosarcoma | 1 (1.0%) |
Branchial cyst | 1 (1.0%) |
Metastasis | 3 (3.0%) |